4.7 Article

Uptake of F-18-Labeled 6-Fluoro-6-Deoxy-D-Glucose by Skeletal Muscle Is Responsive to Insulin Stimulation

Journal

JOURNAL OF NUCLEAR MEDICINE
Volume 50, Issue 6, Pages 912-919

Publisher

SOC NUCLEAR MEDICINE INC
DOI: 10.2967/jnumed.109.062687

Keywords

glucose transport; radiopharmaceutical; PET; glucose clamp

Funding

  1. National Institute of Diabetes and Digestive and Kidney Diseases [DK14507, DK- 61994]
  2. Case Center for Imaging Research
  3. [U24 DK76169]
  4. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082423, U24DK076169, R37DK014507, R01DK061994, R01DK014507] Funding Source: NIH RePORTER

Ask authors/readers for more resources

We are developing a methodology for the noninvasive imaging of glucose transport in vivo with PET and F-18-labeled 6-fluoro-6-deoxy- D-glucose (F-18-6FDG), a tracer that is transported but not phosphorylated. To validate the method, we evaluated the biodistribution of F-18-6FDG to test whether it is consistent with the known properties of glucose transport, particularly with regard to insulin stimulation of glucose transport. Methods: Under glucose clamp conditions, rats were imaged at the baseline and under conditions of hyperinsulinemia. Results: The images showed that the radioactivity concentration in skeletal muscle was higher in the presence of insulin than at the baseline. We also found evidence that the metabolism of F-18-6FDG was negligible in several tissues. Conclusion: F-18-6FDG is a valid tracer that can be used in in vivo transport studies. PET studies performed under glucose clamp conditions demonstrated that the uptake of nonphosphorylated glucose transport tracer F-18-6FDG is sensitive to insulin stimulation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available